Tay-Sachs Disease

References

Citations

1. Chodirker BN, et al. (2001). Canadian guidelines for prenatal diagnosis: Genetic indications for prenatal diagnosis. Journal of the Society of Obstetricians and Gynaecologists of Canada, 105: 1–7.

2. Khoury MJ, et al. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348(1): 50–58.

3. Bach G, et al. (2001). Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. American Journal of Medical Genetics, 99(1): 70–75.

4. Igdoura SA (1999). Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells. Human Molecular Genetics, 8(6): 1111–1116.

5. Martino S, et al. (2005). A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease. Human Molecular Genetics, 14(15): 2113–2123.

Other Works Consulted

• Neudorfer O, Kolodny EH (2004). Late-onset Tay-Sachs disease. Israel Medical Association Journal, 6: 107–111.

Go to previous section	Go to top of page	Go to next section
Author:	Carrie Henley Sabra L. Katz-Wise	Last Updated: June 20, 2006
Medical Review:	Adam Husney, MD - Family Medicine Michael J. Sexton, MD - Pediatrics Renee H. Martin, PhD - Medical Genetics
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.